Skip to main content
Top
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Oral presentation

O211. The state of PI monotherapy and NRTI-sparing therapy

Author: JR Arribas

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Current consensus about treatment of HIV infection is that HAART must include two nucleoside reverse transcriptase inhibitors plus a third drug (one non-nucleoside reverse transcriptase inhibitor, a boosted protease inhibitor, an integrase strand transfer inhibitor and possibly a CCR5 inhibitor). There is a lot of interest about changing the basic structure of the antiretroviral regimen so we can be able to use nucleoside-sparing regimens. The main reason to support the investigation of NRTI-sparing strategies is the concern about the long-term toxicity of tenofovir and abacavir. …
Metadata
Title
O211. The state of PI monotherapy and NRTI-sparing therapy
Author
JR Arribas
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-O17

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue

Poster presentation

Abstract withdrawn